| 000 | 00000cam 2200000zi 4500 |
| 001 | 9.963518 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20260618112010 |
|---|
| 006 | m o d f |
|---|
| 007 | cr cn||||||||| |
|---|
| 008 | 260612t20262026quca ob f000 0 eng d |
|---|
| 020 | |a9780662385233 |
|---|
| 040 | |aCaOODSP|beng|erda|cCaOODSP |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aEn88-19/2026E-PDF |
|---|
| 245 | 00|aNet-zero emissions primer for pharmaceutical manufacturing companies. |
|---|
| 264 | 1|aGatineau, Quebec : |bEnvironment and Climate Change Canada = Environnement et changement climatique Canada, |c2026. |
|---|
| 264 | 4|c©2026 |
|---|
| 300 | |a1 online resource (1 volume (various pagings)) : |billustrations |
|---|
| 336 | |atext|btxt|2rdacontent |
|---|
| 337 | |acomputer|bc|2rdamedia |
|---|
| 338 | |aonline resource|bcr|2rdacarrier |
|---|
| 500 | |aCover title. |
|---|
| 500 | |aIssued also in French under title: Guide d'introduction à la carboneutralité pour l'industrie pharmaceutique. |
|---|
| 500 | |a"Non classifié | Unclassified." |
|---|
| 504 | |aIncludes bibliographical references (pages 30-31). |
|---|
| 520 | |a"The purpose of this Net-Zero Emissions Primer is to help companies and organizations in the pharmaceutical manufacturing industry group in Canada: a) Improve their understanding of the importance of net-zero, and what the transition to net-zero could look like for their subsector and globally; and, b) Develop a net-zero strategy and plan for their organization"--Section 1 Introduction, Purpose of this Primer, page 1. |
|---|
| 650 | 0|aGreenhouse gas mitigation|xGovernment policy|zCanada. |
|---|
| 650 | 0|aPharmaceutical industry|xEnvironmental aspects|zCanada. |
|---|
| 710 | 1 |aCanada. |bEnvironment and Climate Change Canada, |eissuing body. |
|---|
| 775 | 08|tGuide d'introduction à la carboneutralité pour l'industrie pharmaceutique.|w(CaOODSP)9.963519 |
|---|
| 856 | 40|qPDF|s708 KB|uhttps://publications.gc.ca/collections/collection_2026/eccc/En88-19-2026-eng.pdf |
|---|
| 986 | |aEC26145 |
|---|